Fri, June 13, 2025
Thu, June 12, 2025
Wed, June 11, 2025
Tue, June 10, 2025
Mon, June 9, 2025
Sun, June 8, 2025
Sat, June 7, 2025
Fri, June 6, 2025
Thu, June 5, 2025
Wed, June 4, 2025
Tue, June 3, 2025
Mon, June 2, 2025
Sun, June 1, 2025
Sat, May 31, 2025
Fri, May 30, 2025
Thu, May 29, 2025
Wed, May 28, 2025
Tue, May 27, 2025
Mon, May 26, 2025
Sun, May 25, 2025
Sat, May 24, 2025
Fri, May 23, 2025
Thu, May 22, 2025
Wed, May 21, 2025
Tue, May 20, 2025
[ Tue, May 20th ] - 13abc
Moment of Science: Cicadas
Mon, May 19, 2025
Sun, May 18, 2025
Sat, May 17, 2025
Fri, May 16, 2025
Thu, May 15, 2025
Wed, May 14, 2025
Tue, May 13, 2025

When the FDA requires a large vaccine trial, who pays?


//science-technology.news-articles.net/content/2 .. fda-requires-a-large-vaccine-trial-who-pays.html
Published in Science and Technology on by STAT   Print publication without navigation

And more must-read biotech news brought to you by The Readout.

The article from STAT News dated May 20, 2025, discusses several key developments in the biotech industry. Pfizer has acquired Tourmaline Bio for $1.5 billion, aiming to bolster its immunology portfolio. Novavax is facing challenges with its Covid-19 vaccine, reporting a significant drop in sales and contemplating strategic alternatives. Prime Medicine has received FDA clearance for its first clinical trial using prime editing technology, marking a significant step in gene editing. Additionally, the FDA has approved a new CRISPR-based therapy for sickle cell disease, highlighting advancements in genetic treatments. The article also touches on the ongoing debate over vaccine mandates and the impact of recent court rulings on public health policies.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/05/20/biotech-news-pfizer-tourmaline-novavax-prime-crispr-fda-vaccines-the-readout/ ]

Publication Contributing Sources